相似文献
1
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
Science. 1999 Aug 20;285(5431):1276-9. doi: 10.1126/science.285.5431.1276.
2
Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
Circ Res. 2001 Jan 19;88(1):44-51. doi: 10.1161/01.res.88.1.44.
3
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
J Cell Physiol. 2008 Jun;215(3):771-81. doi: 10.1002/jcp.21356.
4
Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids.
J Biol Chem. 2001 May 11;276(19):15983-9. doi: 10.1074/jbc.M100439200. Epub 2001 Feb 22.
5
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Circ Res. 2002 May 17;90(9):1020-7. doi: 10.1161/01.res.0000017727.35930.33.
6
CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
Cell Physiol Biochem. 2015;35(5):2043-54. doi: 10.1159/000374011. Epub 2015 Mar 30.
7
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Arch Biochem Biophys. 2005 Jan 15;433(2):413-20. doi: 10.1016/j.abb.2004.10.009.
8
CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Am J Physiol Endocrinol Metab. 2015 Jan 15;308(2):E97-E110. doi: 10.1152/ajpendo.00366.2014. Epub 2014 Nov 11.
9
EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells.
Int J Mol Med. 2013 Sep;32(3):685-93. doi: 10.3892/ijmm.2013.1435. Epub 2013 Jul 5.
10
Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
PLoS One. 2017 Mar 22;12(3):e0174137. doi: 10.1371/journal.pone.0174137. eCollection 2017.
引用本文的文献
1
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats.
World J Gastroenterol. 2025 Sep 7;31(33):109562. doi: 10.3748/wjg.v31.i33.109562.
2
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs.
Life (Basel). 2025 Aug 13;15(8):1287. doi: 10.3390/life15081287.
3
Obtaining and Characterization of Nutraceuticals Based on Linoleic Acid Derivatives Obtained by Green Synthesis and Their Valorization in the Food Industry.
Nutrients. 2025 Jul 24;17(15):2416. doi: 10.3390/nu17152416.
4
Reprogramming inflammation: Mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators.
Eur J Pharmacol. 2025 Jul 5;1003:177924. doi: 10.1016/j.ejphar.2025.177924.
5
Effects of soluble epoxide hydrolase inhibition on liver injury and gut microbiota in mice chronically fed ethanol.
Alcohol Clin Exp Res (Hoboken). 2025 Jul 3. doi: 10.1111/acer.70109.
6
Association of CYP3A5, ABCB1, and CYP2C8 Polymorphisms with Renal Function in Kidney Transplant Recipients Receiving Tacrolimus.
Eur J Drug Metab Pharmacokinet. 2025 Jul 1. doi: 10.1007/s13318-025-00955-2.
7
Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model.
Mol Neurodegener. 2025 Apr 23;20(1):44. doi: 10.1186/s13024-025-00844-x.
8
A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease.
Int J Mol Sci. 2025 Mar 8;26(6):2433. doi: 10.3390/ijms26062433.
9
Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy.
JACC Basic Transl Sci. 2025 Mar;10(3):367-380. doi: 10.1016/j.jacbts.2024.12.010. Epub 2025 Feb 5.
10
The Hunt for the Putative Epoxyeicosatrienoic Acid Receptor.
ACS Chem Biol. 2025 Apr 18;20(4):762-777. doi: 10.1021/acschembio.5c00047. Epub 2025 Mar 24.
本文引用的文献
1
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.
Circ Res. 1999 Jun 11;84(11):1237-44. doi: 10.1161/01.res.84.11.1237.
2
Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone.
Circ Res. 1999 Mar 5;84(4):484-8. doi: 10.1161/01.res.84.4.484.
3
Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Circ Res. 1998 Nov 2;83(9):932-9. doi: 10.1161/01.res.83.9.932.
4
Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: more than just endothelium-derived hyperpolarizing factor?
Clin Exp Pharmacol Physiol. 1998 Oct;25(10):826-30. doi: 10.1111/j.1440-1681.1998.tb02162.x.
5
Inhibitors of alternative pathways of arachidonate metabolism differentially affect fever in mice.
Am J Physiol. 1998 Oct;275(4):R1031-40. doi: 10.1152/ajpregu.1998.275.4.R1031.
6
Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.
J Biol Chem. 1997 May 9;272(19):12551-9. doi: 10.1074/jbc.272.19.12551.
7
Inhibitors of cytochrome P-450 augment fever induced by interleukin-1 beta.
Am J Physiol. 1996 Nov;271(5 Pt 2):R1274-9. doi: 10.1152/ajpregu.1996.271.5.R1274.
8
Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart.
J Biol Chem. 1996 Feb 16;271(7):3460-8. doi: 10.1074/jbc.271.7.3460.
9
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.
Circ Res. 1996 Mar;78(3):415-23. doi: 10.1161/01.res.78.3.415.
10
Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells.
Biochim Biophys Acta. 1996 Jan 19;1299(2):267-77. doi: 10.1016/0005-2760(95)00216-2.
Zotero 插件